Skip to main content
2025 IDWeek Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Session Icons
Live Streamed
Live Streamed
On Demand
On Demand

H4. HIV: Treatment

Poster Session: HIV: Treatment

(P-365) Pooled safety and tolerability of twice-yearly lenacapavir with teropavimab and zinlirvimab for HIV-1 treatment

Monday, October 20, 2025
12:15 PM - 1:30 PM US ET
Location: Poster Hall B4-B5

    Co-Author(s)

  • Kimberly Workowski, MD

    Professor
    Department of Medicine, Emory University, Atlanta, GA, USA
    Atlanta, Georgia, United States

    • Co-Author(s)

  • PR

    Peter Ruane, MD

    Ruane Clinical Research, Los Angeles, CA, USA
    Los Angeles, California, United States

  • AM

    Anthony Mills, MD

    Chief Medical Officer
    Men's Health Foundation, Los Angeles, CA, USA
    Los Angeles, California, United States

    • Presenting Author(s)

  • Mehri S. McKellar, MD (she/her/hers)

    Professor of Medicine
    Division of Infectious Diseases, Department of Medicine, Duke University School of Medicine, Durham, NC, USA
    Durham, NC, United States

    • Co-Author(s)

  • Olayemi O. Osiyemi, MD

    President
    Triple O Research Institute PA, West Palm Beach, Florida, USA
    West Palm Beach, Florida, United States

  • LG

    Linda Gorgos, MD, MSc, FIDSA

    AXCES Research Group, Santa Fe, NM, USA
    Santa Fe, New Mexico, United States

  • GC

    Gordon E. Crofoot, MD

    The Crofoot Research Center, Houston, TX, USA
    Houston, Texas, United States

  • Moti Ramgopal, MD

    Medical Director
    Midway Immunology and Research Center
    Fort Pierce, Florida, United States

  • CB

    Cynthia C. Brinson, MD

    Medical Director
    Central Texas Clinical Research, Austin, TX, USA
    Austin, Texas, United States

  • KM

    Kwad Mponponsuo, MD, MSc

    Gilead Sciences, Inc., Foster City, CA, USA
    Foster City, California, United States

  • SC

    Sean E. Collins, MD, MS

    Gilead Sciences, Inc., Foster City, CA, USA
    Foster City, California, United States

  • HL

    Hui Liu, PhD

    Director
    Gilead Sciences, Inc., Foster City, CA, USA
    Foster City, California, United States

  • NZ

    Nan Zhang, PhD

    Director of Clinical Pharmacology
    Gilead Sciences, Inc., Foster City, CA, USA
    Foster City, CA, United States

  • KF

    Keith Flower, MD

    Gilead Sciences, Inc., Foster City, CA, USA
    Foster City, California, United States

  • TC

    Tina Chakrabarti, MD

    Gilead Sciences, Inc., Foster City, CA, USA
    Foster City, California, United States

  • Onyema Ogbuagu, MA, FACP, FIDSA

    Associate Professor and Director, Antivirals and vaccines research Program
    Yale School of Medicine, New Haven, CT, USA
    New Haven, Connecticut, United States